Mace Rothenberg

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Douglas Barry, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mace Rothenberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Director Common Stock 37,500 $42,750 $1.14 05 Jun 2025 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 37,500 05 Jun 2025 Direct
Surrozen, Inc./DE Director Option (right to buy) 1,333 14 May 2025 Direct
Surrozen, Inc./DE Director Option (right to buy) 1,333 05 Jun 2024 Direct

Insider Reports Filed by Mace Rothenberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 05 Jun 2025 2 $0 4 Director 09 Jun 2025, 17:47
SRZN Surrozen, Inc./DE 14 May 2025 1 $0 4 Director 15 May 2025, 17:22
TNGX Tango Therapeutics, Inc. 14 Nov 2024 2 +$74,000 4 Director 18 Nov 2024, 19:20
TNGX Tango Therapeutics, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 17:17
SRZN Surrozen, Inc./DE 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 20:30
TNGX Tango Therapeutics, Inc. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 21:40
SRZN Surrozen, Inc./DE 18 May 2023 1 $0 4 Director 19 May 2023, 16:17
TNGX Tango Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:27
SRZN Surrozen, Inc./DE 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 17:50
SRZN Surrozen, Inc./DE 11 Aug 2021 0 $0 3 Director 16 Aug 2021, 19:49
TNGX Tango Therapeutics, Inc. 10 Aug 2021 0 $0 3 Director 12 Aug 2021, 20:38